Introduction
Despite strong homology in their activation domains (AD), DNA-binding domains and tetramerization domains, studies have demonstrated that p53 family members have both common and diverse biological functions. p53 is a critical tumor suppressor as evidenced by the fact that greater than 50% of tumors are p53 null. Loss of p53 function either through mutation, gene silencing or oncogene inactivation promotes genomic instability and increases the likelihood of tumor formation. For example, p53
À/À knockout mice are phenotypically normal at birth, but display a high rate of gene amplifications and spontaneous tumor formation (reviewed in Attardi and Donehower, 2005) . Similarly, Li-Fraumeni syndrome patients carrying germ line mutations in the TP53 locus are prone to develop chromosome abnormalities and have a higher incidence of tumor formation (Boyle et al., 1998) .
p63, a member of the p53 family, is found to play a major role in epithelial development. Germ line mutations in TP63 are associated with skin, hair, tooth and skeletal patterning defects (Brunner et al., 2002) . In addition, p63 À/À mice display defects in epithelial development, fail to maintain epithelial stem cells and die shortly after birth due to dehydration (Mills et al., 1999; Yang et al., 1999) . However, studies linking p63 function to cancer have frequently produced conflicting results. For example, p63 is often overexpressed in head and neck squamous cell carcinomas and is thought to promote tumorigenesis by blocking the apoptotic function of other p53 family members. In contrast, loss of p63 expression in bladder and breast cancers may lead to increased metastatic potential. Further compounding this matter is that mice heterozygous for p63 or p73 were found to be more prone to tumor formation in one study (Flores et al., 2005) , while earlier p63 knockout mice showed no predisposition to cancer (Mills et al., 1999; Yang et al., 1999) . Additionally, p63 does not contribute to radiation-induced apoptosis in thymocytes (Senoo et al., 2004) , but promotes death receptor and mitochondrial-induced apoptosis (Gressner et al., 2005) . Altogether, these studies suggest that p63 plays a complex role in tumorigenesis that is likely context specific.
The TP63 locus expresses multiple isoforms with variable transcriptional activities (Yang et al., 1998) . The transactivation p63 (TAp63) variant is expressed from the upstream promoter and contains an AD similar to the strong AD1 of p53. Initiation of transcription from a cryptic promoter in intron 3 produces the N-terminal-deleted p63 (DNp63) variant, which lacks the N-terminal AD. In addition, alternative splicing of both TAp63 and DNp63 transcripts yields the a, b and g isoforms encoding unique C termini. Altogether, six unique isoforms are expressed from the TP63 locus: p63a, p63b, p63g, DNp63a, DNp63b and DNp63g (TA prefix is often omitted when referring to the TAp63 variant). Initial study showed that the TAp63 variant is a transcriptional activator, whereas the DNp63 is a dominant-negative inhibitor (Yang et al., 1998) . Further studies in our laboratory and later in others showed that the DNp63 variant is transcriptionally active (Dohn et al., 2001; King et al., 2003) . In addition, we defined the DNp63 AD and identified proline-rich motifs as an integrate part of the DNp63 AD (Helton et al., 2006) . In this study, we showed that all TAp63 isoforms possess the ability to transactivate p53-target genes, inhibit proliferation and induce apoptosis. Surprisingly, we found that the transcriptional activity of the TA variant requires the presence of both the AD and the proline-rich domain. In addition, we demonstrated that deletion of the proline-rich domain greatly attenuates the transactivation and apoptotic potential of TAp63 without affecting its ability to bind DNA or inhibit cell proliferation. Finally, we identified that the PXXP motif at residues 124-127 is necessary for TAp63 transcriptional activity.
Results

TAp63 isoforms are potent transcriptional activators
To characterize the function of the TAp63 isoforms we used the tetracycline-off system to generate stable, inducible cells lines in p53-null H1299 cells derived from a lung adenocarcinoma. Two clones for each TAp63 isoform were selected for further study. TAp63a-11 and TAp63a-14 cell lines, which were also used for a previous study (Dohn et al., 2001) , were further characterized and used here as a control. Western blot analysis revealed that each isoform was expressed and that all TAp63 isoforms were strong transcriptional activators of p21 (Figure 1a ). P21, a cyclin-dependent kinase inhibitor, is associated with both G 1 and G 2 arrest (el-Deiry et al., 1994) . To further analyse the transcriptional activity of these isoforms, we carried out a northern blot analysis using cells treated as described in Figure 1b . We found that among the three TAp63 isoforms, TAp63b induced the highest levels of p21, Hdm2 and PIG3 transcripts, followed by TAp63g and then TAp63a. Our assertion that p63b is the strongest transactivator of endogenous target genes is supported by earlier studies that utilized transient transfections and reporter assays to characterize p63 isoforms (Ghioni et al., 2002) .
TAp63 isoforms inhibit cell proliferation and induce apoptosis
To demonstrate the effect of TAp63 expression on overall cell viability, the growth rate of these p63-producing cells was carried out over a 5-day period. The results showed that all TAp63 isoforms were competent to inhibit cell viability over time in culture (Figure 2a) . Surprisingly, we consistently observed a significant number of cells undergoing some form of cell death after only 1 day of induction. To confirm that the cell death was due to apoptosis, live cells were stained with Annexin V-FITC (MBL International, Woburn, MA, USA) and propidium iodide after 18 h of induction. When analysed by fluorescence-activated cell sorting (FACS) analysis, we found that the cell death induced by TAp63 isoforms was due to apoptosis (Figures 2b and c) . In addition, we showed that consistent with their transcriptional activity, TAp63b possessed the greatest ability to induce apoptosis (25.3±4.6 and 24.9±6.2%), followed by TAp63g (18.3 ± 1.3 and 20.4 ± 0.7%) and then by TAp63a (7.0±0.5 and 10.6±1.4%).
The TAp63 variant requires both the AD and the prolinerich domain to transactivate target gene promoters The domains required for transcriptional activation by the TAp63 isoforms were initially mapped by transiently co-transfecting cDNA expressing different p63 isoforms into H1299 cells along with luciferase reporter constructs driven by the P21, FDXR and GADD45 Generation of stable cell lines that inducibly express TAp63 isoforms. Cells were induced or uninduced to express Myc-tagged TAp63a, TAp63b or TAp63g for 24 h, followed with western blots analysis using antibodies against Myc, p21 and actin. (b) RNA isolated from uninduced (Àp63) and induced cells ( þ p63) was analysed by northern blot and hybridization with radiolabeled cDNA probes for P21, HDM2 and PIG3 genes as indicated to the right of the blot. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was measured as a loading control.
promoters. We showed that p63a, p63b, p63g, DNp63b and DNp63g were competent to transactivate exogenously transfected promoters ( Figure 3a) . Furthermore, the different transcriptional activities inherent to the TA and DN variants and the contributions of the a, b and g C termini were also revealed although the expression levels of these p63 isoforms were comparable ( Figure 3b ). To examine if other domains are required for TAp63 transactivation potential, we generated TAp63b deletion constructs, including TAp63b(D2-59), which lacks the potent AD between residues 2-59, TAp63b(DPRD), which lacks the proline-rich domain between residues 60-133 and TAp63b(D501-ter), which is truncated in the C terminus along with the PPXY motif between residues 501 and 504 (Figure 3c ). Interestingly, we found that deletion of either the AD or the proline-rich domain, but not the C terminus, was able to abolish the transactivation potential of TAp63b (Figure 3d ) although the expression levels of TAp63b(D2-59) and TAp63b(D30-133) were much higher than that of wild-type TAp63b and TAp63b(D501-ter) mutant (Figure 3e ). Similar results were also obtained with the FDXR and GADD45 promoters (data not shown). In addition, our data suggest that the C-terminal PPXY motif, which is a major contributor to DNp63b transactivation potential (Helton et al., 2006) , may be less critical to TAp63 isoforms. Still, the differences between TAp63b and TAp63g activities illustrated herein suggest some role for the b and g C termini in regulating protein function. Altogether these data suggest that both the AD and proline-rich domain are required for TAp63 transcriptional activity.
Deletion of the proline-rich domain greatly attenuates the ability of TAp63b to induce endogenous gene expression in H1299 cell lines To further explore the role of the proline-rich domain in p63 function, we generated multiple stable cells lines inducibly expressing TAp63b(DPRD). Two representative clones, DPRD-8 and DPRD-12, were selected for further study. Western blot analysis showed that TAp63b(DPRD) was expressed upon induction (Figure 4a) . Moreover, we found that the ability of TAp63b to induce p21, hdm2 and fdxr was greatly attenuated by deletion of the proline-rich domain even though the levels of TAp63b(DPRD) were expressed much higher than that of TAp63b (Figure 4a ). Furthermore, northern blot analysis was carried out to confirm the attenuated transcriptional activity by deletion of the proline-rich domain. We showed that TAp63b(DPRD) failed to significantly induce transcripts of P21, HDM2, PIG3 and FDXR genes (Figure 4b) .
Deletion of the proline-rich domain greatly reduces the ability of p63 to induce apoptosis but not growth inhibition Next, we examined whether deletion of the proline-rich domain has an effect on the ability of TAp63b(DPRD) to regulate overall cell viability. We found that despite the loss of transcriptional activity (Figures 3d, 4a and b) , Figure 3 The TAp63 variant requires both the activation domain and the proline-rich domain to transactivate target gene promoters. (a) The ability of TAp63 isoforms to regulate the P21, FDXR and GADD45 promoters was measured by luciferase reporter assay. (b) TA/DNp63 isoforms are expressed at a comparable level. (c) Graphical representation of TAp63b constructs: wild-type p63b, p63b(DAD) deleted of residues 2-59 containing the activation domain, TAp63b(DPRD) deleted of residues 60-133 containing the proline-rich domain and TAp63(D501-ter), which is truncated in the C terminus along with the PPXY motif between residues 501 and 504. (d) TAp63b(DAD) and TAp63b(DPRD) are transcriptionally inert to the P21 promoter. The dual-luciferase assay was carried out as described in the 'Materials and methods' section. The increase in relative luciferase activity for each construct was calculated using an empty vector as a control. (e) TAp63b and its deletion mutants are expressed from various p63 constructs. TAp63b(DPRD) was still capable of inducing growth inhibition (Figure 5a ). To test if the inhibited cell growth was due to apoptosis, we carried out an apoptosis assay and showed that the proapoptotic function of TAp63b(DPRD) was significantly attenuated (5 ± 0.9 and 4.6 ± 0.2%) compared to wild-type p63b (15±0.9%) (Figures 5b and c) . In addition, DNA histogram analysis showed that the extent of sub-G 1 accumulation, indicative of apoptotic DNA fragmentation, was markedly reduced in TAp63b(DPRD) expressing cells (6 ± 1.9 and 2.1 ± 0.3%) compared to wild-type p63 expressing cells (34 ± 6.9%) (Figures 5d and e) . p63b(DPRD) inhibits wild-type p63b transactivation function in a dominant-negative manner that does not compromise DNA-binding potential To explore the mechanism by which TAp63b(DPRD) loses its biological activity, a competitive luciferase assay was carried out by co-transfecting varying amount of cDNA expressing wild-type TAp63b and TAp63b(DPRD) along with the P21 luciferase reporter. We found that TAp63b(DPRD) is dominant-negative toward wild-type TAp63b in a dose-dependent manner (Figure 6a ). To examine whether deletion of the proline-rich domain affected DNA binding, a chromatin immunoprecipitation (ChIP) assay was carried out using cell lines p63b-30 and p63b(DPRD)-8. Following immunoprecipitation of Figure 4 Deletion of the proline-rich domain greatly attenuates TAp63 transcriptional activity in H1299 cell lines. (a) Cells were induced or uninduced to express wild-type TAp63b or TAp63b(DPRD) for 18 h, followed with western blot analysis using antibodies against Myc, hdm2, fdxr, p21 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (b) Cells were treated as described in (a) and total RNAs were isolated for preparing northern blots. Radiolabeled cDNA probes for P21, HDM2, PIG3 and FDXR genes were used to hybridize northern blot membrane. GAPDH levels were measured as a loading control. protein-DNA complexes, we showed that both wild types TAp63b and TAp63b(DPRD) were found to bind the P21 and FDXR promoters (Figure 6b ).
Mutational analysis of the proline-rich domain identifies a PXXP motif as a major contributor to p63b transactivation potential Given that TAp63b(DPRD) loss of function was not due to a DNA-binding defect, we carried out mutational analysis of the proline-rich domain to identify potential sequences that might contribute to TAp63 transactivation potential. Knowing that proline-rich motifs can function as protein-protein interaction sites, we chose to disrupt the two PXXP motifs, where P is a proline and X is any amino acid, present in the proline-rich domain of the TAp63 variant by generating a point mutation converting the second proline to an alanine (Figure 7a) . When co-transfected with the P21 luciferase reporter, we found that transactivation potential of TAp63b(P70A) was comparable to that of wild-type TAp63b. However, a significant loss of transactivation potential was consistently observed when the PXXP motif at residues 124-127 of TAp63b was disrupted separately, as with TAp63b(P127A), or in conjunction with the other PXXP motif at residues 67-70, as with TAp63b(P70A/P127A).
Discussion
Here we report that the proline-rich domain is critical for p63 to function as a transcriptional activator. Significantly, deletion of the proline-rich domain or deletion of the AD resulted in a similar loss of function as measured by the luciferase reporter assay (Figure 3d ). This loss of function was also seen with endogenous target gene activation, as TAp63b(DPRD) expressed in stable, inducible cell lines has drastically reduced transactivation potential when assayed by western or northern blot analysis (Figures 4a and b) . Interestingly, the loss of function phenotype reported here is similar to that described for p53 deleted of its PRD (Baptiste et al., 2002; Zhu et al., 1999) . For example, the ability of p53(DPRD), which lacks residues 62-91, to transactivate certain target genes was greatly attenuated, compared to that seen with wild-type p53 (Walker and Figure 6 TAp63b(DPRD) inhibits wild-type p63b transactivation function in a dominant-negative manner that does not compromise DNA-binding potential. (a) Varying amount of pcDNA3 expression vectors were transiently transfected into H1299 cells along with 100 ng pGL2-P21 and 10 ng of Renilla control vector. Total DNA transfected was kept constant at 710 ng per well using an empty pcDNA3 vector. Graph represents the fold increase (mean±s.d.) in luciferase activity from three separately analysed samples. (b) Chromatin immunoprecipitation of myc-tagged TAp63b and TAp63b(DPRD) was carried out using an anti-myc antibody (Ab9106). Rabbit IgG was used for a negative control. Levine, 1996; Zhu et al., 1999; Baptiste et al., 2002) . In addition, similar to our results reported here, p53(DPRD) was not competent to induce apoptosis, but retained the ability to inhibit cell proliferation (Zhu et al., 1999) . The similarity of these results is surprising since p53 and p63 share little homology in their PRD: five PXXP motifs in human p53 PRD and two PXXP motifs in human p63 PRD (Figure 7c) . Furthermore, while the proline-rich domain for p63 is highly conserved across species, the PRD of p53 is not. For instance, mouse p53 contains a PRD with only two PXXP motifs, which shares only 43% amino-acid identity with its human counterpart (Edwards et al., 2003) . In addition, the p53 codon 72 polymorphism encoding a proline, instead of an arginine, which reduces the proapoptotic function of p53, is found in human but not mouse (Phang and Sabapathy, 2007) . Altogether, these results suggest that the PRD for p53 family members contributes to their proapoptotic potential and may be differentially regulated by specific signaling pathways. Given the lack of conservation seen with the p53 PRD, it is likely that modifications of and protein interactions with the p53 PRD differ significantly from species to species. Conversely, the p63 PRD is highly conserved, suggesting that the sequences therein are critical for normal p63 function. Further analysis of this domain is required to identifying signaling pathways interacting with p63 and regulating p63 function through the modulation of the proline-rich domain.
Materials and methods
Cell culture
Stable, inducible cell lines were generated in H1299 cells using the tetracycline-off system as previously described (Chen et al., 1996) . Transfections were carried out using the calcium phosphate precipitation method (Chen, 1987) .
Apoptosis assay
Following an 18 h induction, both floating and adhered cells were collected and washed in cold phosphate-buffered saline (PBS). Staining was carried out using an Annexin V-FITC and propidium iodide staining kit (MBL, Japan) as suggested by the manufacturer. The experiment was carried out in triplicate with data expressed as the mean number of Annexin V positive cells±s.d.
Chromatin immunoprecipitation assay H1299 cells were seeded at 3.0 Â 10 6 cells per 10-cm dish, followed with or without protein expression for 24 h. After induction, p63-DNA complexes were cross-linked by formaldehyde and used for ChIP assay as previously described (Harms and Chen, 2005) . PCR conditions and primer sequences were used as previously described (Liu and Chen, 2002; Willis et al., 2004) .
DNA histogram analysis
Analysis was carried out as previously described (Helton et al., 2006) . Briefly, 3 Â 10 5 cells were plated per 10-cm dish, followed with or without p63 expression for 48 h. After induction, both floating and dead cells were collected and fixed with 2 ml of 75% ethanol overnight and resuspended in 300 ml of PBS solution containing 50 mg each of RNase A (Sigma, St Louis, MO, USA) and propidium iodide (Molecular Probes Inc., Eugene, OR, USA) per ml. FACS data were collected using a FACSCalibur cell sorter (BD Biosciences, Franklin Lakes, NJ, USA). The percentage of cells in each phase of the cell cycle was analysed using Cell Quest software. The percentage of sub-G 1 accumulation was used as a marker of apoptosis.
Growth curve analysis
The overall viability of each cell line was addressed by growth curve analysis, as previously described (Helton et al., 2006) . Briefly, cells were plated at a density of 5 Â 10 4 cells per 6-cm dish and with or without tetracycline. Adherent cells were counted at 24 h intervals over a 5-day period using a Coulter cell counter (Fullerton, CA, USA). Medium was changed at day 3 for both control and experimental cell groups.
Luciferase assay
Transient transfections were carried out using the ESCORT V reagent (Sigma). Briefly, H1299 cells were plated at 5 Â 10 4 cells per well in 12-well plates for 12 h and then co-transfected with 100 ng of activator in pcDNA3 expression vector, 100 ng of pGL2 reporter vector and 10 ng of pRL-CMV, as an internal control. Cell extracts were prepared 36 h after transfection and used for the dual-luciferase assay according to the manufacturer's instructions (Promega, Madison, WI, USA). The increase in relative luciferase activity is a product of the luciferase activity induced by activator divided by that induced by an empty vector. The reporter constructs, pGL2-basic-p21 (full-length promoter), pGL2-Fos-GADD45 (intron 1 RE) and pGL2-basic-FDXR (À56 to ± 11 promoter) were described in previous studies (Liu and Chen, 2002) . All experiments were repeated in triplicate.
Northern blot analysis
Cells were plated at a density of 2.5 Â 10 6 cells per 10-cm dish and incubated for indicated amount of time. Total RNA was isolated and subjected to prepare northern blots. The cDNA probes for P21, HDM2, PIG3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were prepared as previously described (Zhu et al., 1999) .
Western blot analysis
Western blot analysis was carried out as previously described (Helton et al., 2006) . Blots were developed using the following antibodies and conditions: Myc antibody at 1:3000 (Ab9106; Abcam, Cambridge, MA, USA), p21 antibody at 1:2000 (C19; Santa Cruz Biotechnology Inc.; Santa Cruz, CA, USA), fdxr antibody and anti-actin polyclonal antibody at 1:5000 (Sigma) and secondary anti-rabbit-HRP at 1:5000 (Sigma).
